Original Research
Accepted on 02 Mar 2026
Timing-Specific Efficacy of Antiviral Baloxavir and Anti-inflammatory Oclacitinib Monotherapies, and the Benefits of Their Combination in Treating Influenza in Mice
in Antimicrobials, Resistance and Chemotherapy